137 related articles for article (PubMed ID: 35942551)
1. Lower expression of KAI1 as a biomarker of poor survival prognosis of melanoma combined with colorectal cancer metastasis.
Du X; Wang B; Liu L; Li Y; Wang ZX; Zhang GJ; Yang XF
J Int Med Res; 2022 Aug; 50(8):3000605221116758. PubMed ID: 35942551
[TBL] [Abstract][Full Text] [Related]
2. miRNA-633 and KAI1 as Potential Biomarkers of Malignant Melanoma with Gastric Cancer.
Wang ZX; Zhang GJ; Yang XF; Feng SJ; Ji SS; Qi YB
Comb Chem High Throughput Screen; 2023; 26(5):1001-1014. PubMed ID: 35713138
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the correlation of KAI1/CD82, CD44, MMP7 and β-catenin in the prediction of prognosis and metastasis in colorectal carcinoma.
Wu Q; Yang Y; Wu S; Li W; Zhang N; Dong X; Ou Y
Diagn Pathol; 2015 Sep; 10():176. PubMed ID: 26408312
[TBL] [Abstract][Full Text] [Related]
4. KAI1/CD82 and cyclin D1 as biomarkers of invasion, metastasis and prognosis of laryngeal squamous cell carcinoma.
Zhang B; Liu W; Li L; Lu J; Liu M; Sun Y; Jin D
Int J Clin Exp Pathol; 2013; 6(6):1060-7. PubMed ID: 23696923
[TBL] [Abstract][Full Text] [Related]
5. KAI1/CD82 and MRP1/CD9 serve as markers of infiltration, metastasis, and prognosis in laryngeal squamous cell carcinomas.
Zhang BH; Liu W; Li L; Lu JG; Sun YN; Jin DJ; Xu XY
Asian Pac J Cancer Prev; 2013; 14(6):3521-6. PubMed ID: 23886139
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the correlation of vasculogenic mimicry, ALDH1, KAI1 and microvessel density in the prediction of metastasis and prognosis in colorectal carcinoma.
Zhu B; Zhou L; Yu L; Wu S; Song W; Gong X; Wang D
BMC Surg; 2017 Apr; 17(1):47. PubMed ID: 28431527
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological significance of cancer stem cells marked by CD133 and KAI1/CD82 expression in laryngeal squamous cell carcinoma.
Yu L; Zhou L; Wu S; Gong X; Feng Z; Ma L; Zhu B; Yao N; Wang D; Dong H
World J Surg Oncol; 2014 Apr; 12():118. PubMed ID: 24758564
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the correlation of vasculogenic mimicry, Notch4, DLL4, and KAI1/CD82 in the prediction of metastasis and prognosis in non-small cell lung cancer.
Wang Y; Yang R; Wang X; Ci H; Zhou L; Zhu B; Wu S; Wang D
Medicine (Baltimore); 2018 Dec; 97(52):e13817. PubMed ID: 30593175
[TBL] [Abstract][Full Text] [Related]
9. [Expression of CD82/KAI1 and HIF-1α in non-small cell lung cancer and their relationship to vasculogenic mimicry].
Wu S; Cheng Z; Yu L; Song W; Tao Y
Zhongguo Fei Ai Za Zhi; 2011 Dec; 14(12):918-25. PubMed ID: 22152691
[TBL] [Abstract][Full Text] [Related]
10. Down Regulation of KAI1/CD82 in Lymph Node Positive and Advanced T-Stage Group in Breast Cancer Patients.
Krishna Latha T; Verma A; Thakur GK; Banerjee B; Kaur N; Singh UR; Sharma S
Asian Pac J Cancer Prev; 2019 Nov; 20(11):3321-3329. PubMed ID: 31759355
[TBL] [Abstract][Full Text] [Related]
11. KAI1/CD82 expression as a prognosic factor in sporadic colorectal cancer.
Muneyuki T; Watanabe M; Yamanaka M; Shiraishi T; Isaji S
Anticancer Res; 2001; 21(5):3581-7. PubMed ID: 11848527
[TBL] [Abstract][Full Text] [Related]
12. CD82/KAI1 inhibits invasion and metastasis of esophageal squamous cell carcinoma via TGF-β1.
Zeng TD; Zheng B; Zheng W; Chen C
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5928-5937. PubMed ID: 30280774
[TBL] [Abstract][Full Text] [Related]
13. Metabolomic Detection Between Pancreatic Cancer and Liver Metastasis Nude Mouse Models Constructed by Using the PANC1-KAI1/CD
Wang S; Chen J; Li H; Qi X; Liu X; Guo X
Technol Cancer Res Treat; 2021; 20():15330338211045204. PubMed ID: 34605330
[No Abstract] [Full Text] [Related]
14. Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer.
Adachi M; Taki T; Ieki Y; Huang CL; Higashiyama M; Miyake M
Cancer Res; 1996 Apr; 56(8):1751-5. PubMed ID: 8620488
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of the metastasis suppressor protein KAI1/CD82 correlates with occurrence of metastasis, prognosis and presence of HPV DNA in human penile squamous cell carcinoma.
Protzel C; Kakies C; Kleist B; Poetsch M; Giebel J
Virchows Arch; 2008 Apr; 452(4):369-75. PubMed ID: 18305955
[TBL] [Abstract][Full Text] [Related]
16. Decreased expression of KAI1/CD82 metastasis suppressor gene is associated with loss of heterozygosity in melanoma cell lines.
Kim YI; Shin MK; Lee JW; Chung JH; Lee MH
Oncol Rep; 2009 Jan; 21(1):159-64. PubMed ID: 19082457
[TBL] [Abstract][Full Text] [Related]
17. Expression and clinical significance of CD82/KAI1 and E-cadherin in non-small cell lung cancer.
Shiwu WU; Lan Y; Wenqing S; Lei Z; Yisheng T
Arch Iran Med; 2012 Nov; 15(11):707-12. PubMed ID: 23102249
[TBL] [Abstract][Full Text] [Related]
18. MiR-338-5p promotes the growth and metastasis of malignant melanoma cells via targeting CD82.
Long J; Luo J; Yin X
Biomed Pharmacother; 2018 Jun; 102():1195-1202. PubMed ID: 29710538
[TBL] [Abstract][Full Text] [Related]
19. Expression and clinical significance of p53, JunB and KAI1/CD82 in human hepatocellular carcinoma.
Guo C; Liu QG; Zhang L; Song T; Yang X
Hepatobiliary Pancreat Dis Int; 2009 Aug; 8(4):389-96. PubMed ID: 19666408
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of miR-193a-5p correlates with lymph node metastasis and poor prognosis in colorectal cancer.
Zhang P; Ji DB; Han HB; Shi YF; Du CZ; Gu J
World J Gastroenterol; 2014 Sep; 20(34):12241-8. PubMed ID: 25232258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
